| scholarly article | Q13442814 |
| P50 | author | Stefanie Dimmeler | Q110856 |
| Andreas Zeiher | Q501318 | ||
| Christopher Heeschen | Q18347525 | ||
| Carmen Urbich | Q86379417 | ||
| Alexandra Aicher | Q86950497 | ||
| Ken-Ichiro Sasaki | Q89860252 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| limb ischemia | Q18553514 | ||
| P304 | page(s) | 2823–2830 | |
| P577 | publication date | 2006-12-19 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia | |
| P478 | volume | 114 |
| Q89249390 | A multicenter trial of extracorporeal cardiac shock wave therapy for refractory angina pectoris: report of the highly advanced medical treatment in Japan |
| Q64062389 | A systematic review of the long-term efficacy of low-intensity shockwave therapy for vasculogenic erectile dysfunction |
| Q37183949 | Aging and disease as modifiers of efficacy of cell therapy |
| Q53001553 | Alteration of inflammatory response by shock wave therapy leads to reduced calcification of decellularized aortic xenografts in mice†. |
| Q50279365 | Augmented neovascularization with magnetized endothelial progenitor cells in rats with hind-limb ischemia |
| Q35644192 | Biomechanics analysis for the treatment of ischemic necrosis of the femoral head by using an interior supporting system. |
| Q30484643 | Bone healing induced by ESWT. |
| Q44254145 | Bone marrow cell therapies in ischemic cardiomyopathy |
| Q37194005 | Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction. |
| Q33484516 | Call for a reference model of chronic hind limb ischemia to investigate therapeutic angiogenesis |
| Q54339513 | Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention? |
| Q61958028 | Cardiac Cell Therapy: The Next (Re)Generation |
| Q37800141 | Cardiac cell therapies: the next generation |
| Q36087505 | Cardiac shock wave therapy and myocardial perfusion in severe coronary artery disease |
| Q48391538 | Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective placebo-controlled randomized trial |
| Q37294677 | Cardiac shock wave therapy: assessment of safety and new insights into mechanisms of tissue regeneration |
| Q37696967 | Cell therapy for the treatment of coronary heart disease: a critical appraisal |
| Q37783940 | Clinical Application of Stem Cells in the Cardiovascular System |
| Q38601379 | Clinical effect of cardiac shock wave therapy on patients with ischaemic heart disease: a systematic review and meta-analysis |
| Q39790256 | Commentary to low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model, published in J Sex Med 2016;13:22-32 by Li H, Matheu P, Sun F, et al. |
| Q61651435 | Delivery of Biologics in Cardiovascular Regenerative Medicine |
| Q42137893 | Development of Femoral Head Interior Supporting Device and 3D Finite Element Analysis of its Application in the Treatment of Femoral Head Avascular Necrosis |
| Q50246708 | Effect of shock wave treatment on platelet-rich plasma added to osteoblast cultures |
| Q84569881 | Effectiveness of ESWT in the treatment of Kienböck's disease |
| Q41336279 | Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model |
| Q82470989 | Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study |
| Q57167048 | Efficient Promotion of Autophagy and Angiogenesis Using Mesenchymal Stem Cell Therapy Enhanced by the Low-Energy Shock Waves in the Treatment of Erectile Dysfunction |
| Q51161546 | Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia. |
| Q30361688 | Emerging non-cancer applications of therapeutic ultrasound. |
| Q44449397 | Endogenous Stem Cells Were Recruited by Defocused Low-Energy Shock Wave in Treating Diabetic Bladder Dysfunction. |
| Q41810175 | Endothelial progenitor cells homing and renal repair in experimental renovascular disease |
| Q49124402 | Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial |
| Q52609168 | Exposure of zebra mussels to extracorporeal shock waves demonstrates formation of new mineralized tissue inside and outside the focus zone. |
| Q50574004 | Extracorporeal Shock Wave Therapy Accelerates Regeneration After Acute Skeletal Muscle Injury. |
| Q58695517 | Extracorporeal Shock Wave-Supported Adipose-Derived Fresh Stromal Vascular Fraction Preserved Left Ventricular (LV) Function and Inhibited LV Remodeling in Acute Myocardial Infarction in Rat |
| Q90259886 | Extracorporeal Shock Waves Therapy Delivered by Aries Improves Erectile Dysfunction in Spontaneously Hypertensive Rats Through Penile Tissue Remodeling and Neovascularization |
| Q35941282 | Extracorporeal shock wave effectively attenuates brain infarct volume and improves neurological function in rat after acute ischemic stroke |
| Q38014086 | Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy |
| Q34978744 | Extracorporeal shock wave therapy ameliorates cyclophosphamide-induced rat acute interstitial cystitis though inhibiting inflammation and oxidative stress-in vitro and in vivo experiment studies |
| Q30381245 | Extracorporeal shock wave therapy does not improve hypertensive nephropathy. |
| Q36516664 | Extracorporeal shock wave therapy effectively prevented diabetic neuropathy |
| Q37918523 | Extracorporeal shock wave therapy for ischemic cardiovascular disorders |
| Q30474155 | Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment |
| Q41550812 | Extracorporeal shock wave treatment attenuated left ventricular dysfunction and remodeling in mini-pig with cardiorenal syndrome |
| Q90825561 | Extracorporeal shock wave-assisted adipose-derived fresh stromal vascular fraction restores the blood flow of critical limb ischemia in rat |
| Q30489553 | Extracorporeal shock waves as curative therapy for varicose veins? |
| Q47726467 | Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy. |
| Q37412087 | Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis |
| Q37096297 | Homing and engraftment of progenitor cells: a prerequisite for cell therapy |
| Q26774939 | How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart? |
| Q30363630 | Improving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound. |
| Q42137105 | Intracoronary Infusion of Autologous CD133(+) Cells in Myocardial Infarction and Tracing by Tc99m MIBI Scintigraphy of the Heart Areas Involved in Cell Homing |
| Q35102931 | Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival |
| Q90568114 | Low-Energy Extracorporeal Shock Wave Ameliorates Streptozotocin Induced Diabetes and Promotes Pancreatic Beta Cells Regeneration in a Rat Model |
| Q92241345 | Low-Energy Extracorporeal Shock Wave Therapy Ameliorates Kidney Function in Diabetic Nephropathy |
| Q46634358 | Low-Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation |
| Q47571172 | Low-Intensity Extracorporeal Shock Wave as a Novel Treatment for Erectile Dysfunction |
| Q38632211 | Low-energy shock wave preconditioning reduces renal ischemic reperfusion injury caused by renal artery occlusion |
| Q42343425 | Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model |
| Q53062423 | Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study. |
| Q30444179 | Low-intensity shock wave therapy and its application to erectile dysfunction |
| Q90947525 | Low-intensity shockwave therapy for erectile dysfunction in kidney transplant recipients. A prospective, randomized, double blinded, sham-controlled study with evaluation by penile Doppler ultrasonography |
| Q38662843 | Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough? |
| Q48045059 | Magnetic resonance elastography can monitor changes in medullary stiffness in response to treatment in the swine ischemic kidney |
| Q92218851 | Management of Refractory Angina Pectoris |
| Q28073614 | Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders |
| Q38758282 | Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction |
| Q57495833 | New Advances in the Management of Refractory Angina Pectoris |
| Q34664336 | New approaches to the design and discovery of therapies to prevent erectile dysfunction |
| Q26859821 | Penile low-intensity shock wave therapy: a promising novel modality for erectile dysfunction. |
| Q91783609 | Physical energies to the rescue of damaged tissues |
| Q37016190 | Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure |
| Q33745065 | Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol |
| Q52657125 | Recent Progress in Stem Cell Modification for Cardiac Regeneration. |
| Q36530167 | Recruiting endogenous stem cells: a novel therapeutic approach for erectile dysfunction |
| Q47744623 | Regenerative Stem Cell Therapy Optimization via Tissue Engineering in Heart Failure with Reduced Ejection Fraction |
| Q42049134 | Role of extracorporeal shock wave therapy in management of Peyronie's disease: A preliminary report |
| Q46484575 | Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris |
| Q37604051 | Shock Wave Enhances Angiogenesis through VEGFR2 Activation and Recycling |
| Q58699236 | Shock Wave Therapy Enhances Mitochondrial Delivery into Target Cells and Protects against Acute Respiratory Distress Syndrome |
| Q58121752 | Shock Wave Therapy Improves Cardiac Function in a Model of Chronic Ischemic Heart Failure: Evidence for a Mechanism Involving VEGF Signaling and the Extracellular Matrix |
| Q61869584 | Shock Waves in the Treatment of Stress Fractures |
| Q36149685 | Shock wave treatment after hindlimb ischaemia results in increased perfusion and M2 macrophage presence |
| Q34245084 | Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation |
| Q30473582 | Shock wave treatment in composite tissue allotransplantation |
| Q44352275 | Shockwave therapy in patients with peripheral artery disease. |
| Q30455715 | Shockwave treatment of erectile dysfunction |
| Q37693439 | Shockwaves prevent from heart failure after acute myocardial ischaemia via RNA/protein complexes |
| Q36335619 | Short-term efficacy and safety of low-intensity extracorporeal shock wave therapy in erectile dysfunction: a systematic review and meta-analysis |
| Q34981433 | Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges |
| Q36599286 | Stem cell recruitment after injury: lessons for regenerative medicine |
| Q50237623 | Study of the Safety of Extracorporeal Cardiac Shock Wave Therapy: Observation of the Ultrastructures in Myocardial Cells by Transmission Electron Microscopy |
| Q30475246 | Study of vascular injuries using endothelial denudation model and the therapeutic application of shock wave: a review. |
| Q37328786 | The advancing field of cell-based therapy: insights and lessons from clinical trials. |
| Q41630374 | The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina |
| Q37325686 | The potential of stem cells in the treatment of cardiovascular diseases |
| Q90213463 | The role of ultrasound in enhancing mesenchymal stromal cell-based therapies |
| Q91168832 | Therapeutic areas of Li-ESWT in sexual medicine other than erectile dysfunction |
| Q40202451 | Toll-like receptor 3 signalling mediates angiogenic response upon shock wave treatment of ischaemic muscle. |
| Q37570669 | Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases |
| Q38173640 | Treatment of refractory angina in patients not suitable for revascularization |
| Q52592758 | Treatment of stress urinary incontinence with low-intensity extracorporeal shock wave therapy in a vaginal balloon dilation induced rat model. |
| Q34677900 | Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors |
| Q47267502 | Urodynamic and molecular characteristics of detrusor underactivity in a rat cryoinjury model and effects of low energy shock wave therapy |
Search more.